Yidu Tech (HKSE:02158) Change In Working Capital : HK$0.0 Mil (TTM As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Yidu Tech Change In Working Capital?

Yidu Tech's change in working capital for the quarter that ended in Sep. 2023 was HK$0.0 Mil.

Yidu Tech's change in working capital for the fiscal year that ended in Mar. 2023 was HK$47.7 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Yidu Tech Change In Working Capital Historical Data

The historical data trend for Yidu Tech's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yidu Tech Change In Working Capital Chart

Yidu Tech Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Change In Working Capital

Get a 7-Day Free Trial

14.54

-97.72

-93.74

-169.46

47.72

Yidu Tech Semi-Annual Data
	Mar18	Mar19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Change In Working Capital	Get a 7-Day Free Trial					-	-	-	-	-

Yidu Tech Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Yidu Tech Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Yidu Tech's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Yidu Tech (HKSE:02158) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yidu Tech Inc (HKSE:02158) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

0EL:Germany

Address

No.9 Building of Huayuan North Road, 8th Floor Health Work, Haidian District, Beijing, CHN

Website

https://www.yidutechgroup.com

Yidu Tech offers healthcare Big Data. It is an AI cloud-based firm providing solutions and tools to aid in more informed decisions to drive better efficiency in clients' strategies. Its clients are hospitals, pharmaceutical, biotech and medical device firms, research institutions, insurance companies, patients, and regulators. It three business segments are: Big Data platform and solutions, which partners with hospitals and policymakers to drive better efficiency; life sciences solutions, which enables better probability of clinical trial success with less drug development time and cost; and health management solutions, which helps with patient management. The Big Data platform accounted for 33% of revenue, life science solutions 30%, and health management solutions 27%, in fiscal 2022.

Executives

Gong Yingying	2202 Interest of your spouse
Xu Jiming	2101 Beneficial owner
Brunei Investment Agency	2101 Beneficial owner
Gic Private Limited	2102 Investment manager
Sweet Panda Limited	2101 Beneficial owner

Yidu Tech (HKSE:02158) Headlines

No Headlines